MDRX logo

Veradigm (MDRX) News & Sentiment

Veradigm agrees to board refreshment in settlement with Kent Lake Capital
Veradigm agrees to board refreshment in settlement with Kent Lake Capital
Veradigm agrees to board refreshment in settlement with Kent Lake Capital
MDRX
reuters.comFebruary 20, 2025

Veradigm will add four new directors to its board in an agreement with investor Kent Lake Capital, the healthcare technology company said on Thursday just weeks after concluding a strategic review.

Veradigm Introduces Cardiometabolic Clinical Registry Datasets to Enhance the Next Generation of Real-World Research
Veradigm Introduces Cardiometabolic Clinical Registry Datasets to Enhance the Next Generation of Real-World Research
Veradigm Introduces Cardiometabolic Clinical Registry Datasets to Enhance the Next Generation of Real-World Research
MDRX
businesswire.comFebruary 18, 2025

CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today the launch of its disease-specific cardiometabolic Clinical Data Registry datasets, which contain de-identified information about patients' health and care for a specific condition or disease. These datasets provide researchers with access to specialty, Natural Language Processing (NLP)-enhanced real-world data to advance the understanding of patient insights and.

Glancy Prongay & Murray LLP Announces Investigation of Veradigm Inc. (MDRX)
Glancy Prongay & Murray LLP Announces Investigation of Veradigm Inc. (MDRX)
Glancy Prongay & Murray LLP Announces Investigation of Veradigm Inc. (MDRX)
MDRX
businesswire.comDecember 9, 2024

NEW YORK--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Veradigm Inc. (OTCMKTS: MDRX) concerning the Company and its directors' and officers' possible violations of state laws. If you own Veradigm stock, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Tom Kennedy, of GPM, 230 Park Avenue, Suite 358, New York, NY 10169 at tkennedy@gla.

Veradigm Advancing Point of Care Engagement Through Payer-Provider Collaboration
Veradigm Advancing Point of Care Engagement Through Payer-Provider Collaboration
Veradigm Advancing Point of Care Engagement Through Payer-Provider Collaboration
MDRX
businesswire.comNovember 19, 2024

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced an enhanced strategic collaboration with Insiteflow, an electronic health record (EHR) decision workflow platform. This effort expands Veradigm Payer Insights (VPI) beyond the Veradigm EHR footprint into additional EHRs technologies. Together, Veradigm and Insiteflow are placing actionable insights on behalf of Payers at the point of care across multiple EHR platf.

Veradigm Named as the Top Vendor for End-to-End Revenue Cycle Management Solutions
Veradigm Named as the Top Vendor for End-to-End Revenue Cycle Management Solutions
Veradigm Named as the Top Vendor for End-to-End Revenue Cycle Management Solutions
MDRX
businesswire.comAugust 29, 2024

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book™, a healthcare-centric market research and public opinion research and consulting company, rated Veradigm Payerpath the overall number one vendor for end-to-end revenue cycle management (RCM) solutions for physician practice software and services. “At Veradigm, we are dedicated to seamlessly connecting providers with patients and payers. Veradigm P.

The Portnoy Law Firm Announces Investigation of Veradigm Inc. (OTCMKTS: MDRX)
The Portnoy Law Firm Announces Investigation of Veradigm Inc. (OTCMKTS: MDRX)
The Portnoy Law Firm Announces Investigation of Veradigm Inc. (OTCMKTS: MDRX)
MDRX
globenewswire.comJune 10, 2024

Investors can contact the law firm at no cost to learn more about recovering their losses.

Robbins LLP Reminds MDRX Stockholders it is Investigating the Officers and Directors of Veradigm Inc. to Determine if They Breached Fiduciary Duties Owed to Shareholders
Robbins LLP Reminds MDRX Stockholders it is Investigating the Officers and Directors of Veradigm Inc. to Determine if They Breached Fiduciary Duties Owed to Shareholders
Robbins LLP Reminds MDRX Stockholders it is Investigating the Officers and Directors of Veradigm Inc. to Determine if They Breached Fiduciary Duties Owed to Shareholders
MDRX
businesswire.comJune 7, 2024

SAN DIEGO--(BUSINESS WIRE)---- $MDRX #IPO--Robbins LLP is Investigating Allegations Veradigm Inc. (MDRX) Violated Securities Laws in Connection with Misstatements in Financial Reporting.

Robbins LLP Informs Investors it is Investigating the Officers and Directors of Veradigm Inc. (MDRX) for Breaches of Fiduciary Duty
Robbins LLP Informs Investors it is Investigating the Officers and Directors of Veradigm Inc. (MDRX) for Breaches of Fiduciary Duty
Robbins LLP Informs Investors it is Investigating the Officers and Directors of Veradigm Inc. (MDRX) for Breaches of Fiduciary Duty
MDRX
globenewswire.comJune 3, 2024

SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Veradigm Inc. (OTC: MDRX) to determine whether certain Veradigm officers and directors violated securities laws and breached fiduciary duties to shareholders in connection with misstatements in the Company's financial reporting. Veradigm is a healthcare technology company that provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally.

Veradigm Payerpath Rated Highest in Client Satisfaction
Veradigm Payerpath Rated Highest in Client Satisfaction
Veradigm Payerpath Rated Highest in Client Satisfaction
MDRX
businesswire.comMay 30, 2024

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book Research, a healthcare-centric market research and public opinion research and consulting company, rated Veradigm Payerpath the overall number one provider of claims and clearinghouse platform solutions for small medical practices. Veradigm Payerpath achieved top scores in 11 of 18 clearinghouse-focused key performance indicators for solo and indep.

Veradigm to Explore Strategic Alternatives and Reaffirms 2024 Guidance
Veradigm to Explore Strategic Alternatives and Reaffirms 2024 Guidance
Veradigm to Explore Strategic Alternatives and Reaffirms 2024 Guidance
MDRX
businesswire.comMay 28, 2024

CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (OTCMKTS: MDRX, the "Company”), a leading provider of healthcare data and technology solutions, today announced that it has initiated a process to explore strategic alternatives to maximize shareholder value. As part of the evaluation process, Veradigm will explore potential strategic alternatives that may include, but are not limited to, a sale, merger, strategic business combination or other transaction. The Company cannot assure that its exploration wi.

  • 1(current)
  • 2
  • 1(current)
  • 2